Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis

CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.
“Given the fact that this population has a different background, different culture and socioeconomic status, the outcomes aren’t necessarily going to be the same as those from high-income countries,” Hanalise V. Huff, MD, MPH, of the Harvard T.H. Chan School of Public Health, said.
Huff and colleagues sought to examine whether neurologic and neurocognitive symptoms persisted in

CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.
“Given the fact that this population has a different background, different culture and socioeconomic status, the outcomes aren’t necessarily going to be the same as those from high-income countries,” Hanalise V. Huff, MD, MPH, of the Harvard T.H. Chan School of Public Health, said.
Huff and colleagues sought to examine whether neurologic and neurocognitive symptoms persisted in